Skip to content

Abbott

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile12 entries

  1. 2024

    FDA issues Class I recall for Abbott HeartMate pumps

    Recall announced

    The FDA issued its most serious recall for Abbott subsidiary Thoratec's HeartMate II and HeartMate 3 pumps, affecting nearly 14,000 devices. The devices can develop a buildup of biological material that reduces blood-flow capability; the article reports that the recall was linked by the agency to hundreds of injuries and at least 14 deaths.

    Company response

    • Ongoing disclosure — Abbott

      In a written response, Abbott said it had communicated the risk to customers this year.

    Source excerpt

    • A pair of heart devices manufactured by a subsidiary of North Chicago-based Abbott Laboratories has received the FDA’s most serious recall after being linked to hundreds of injuries and at least 14 deaths, the agency has announced.
    • According to the FDA’s recall notice, the devices can cause buildup of “biological material” that reduces their ability to help the heart circulate blood and keep patients alive.
    • The recall affects nearly 14,000 devices.
  2. 2023

    Lawsuit filed over PediaSure height claims

    Lawsuit filed

    Joanne Noriega filed a proposed class action against Abbott Laboratories, alleging that the company misled consumers into believing PediaSure drinks were clinically proven to increase children's height. Abbott said the case was without merit and defended the product's nutritional claims.

    Company response

    • Denial — Abbott

      "This case is without merit," Abbott said in a statement.
    • Denial — Abbott

      The statement also expressed that the allegations in the lawsuit are without merit

    Source excerpt

    • A New York City woman sued Abbott Laboratories on Monday, accusing the healthcare company of misleading consumers into believing its PediaSure nutrition drinks were "clinically proven" to increase children's height.
    • "This case is without merit," Abbott said in a statement. "PediaSure is a scientifically designed complete and balanced nutrition solution for children to help support growth and development."
    • In a proposed class action filed in Manhattan federal court, Joanne Noriega said she bought PediaSure Grow & Gain vanilla and strawberry drinks for her eight-year-old grandson, who was "short for his age," believing they would help him get taller.
  3. 2022

    Sturgis infant-formula contamination investigation and recall

    The FDA investigated complaints involving infants who consumed powdered formula produced at Abbott Nutrition's Sturgis, Michigan, plant. FDA investigators reported Cronobacter sakazakii in environmental samples, adverse inspection observations and company records concerning environmental contamination and product destruction. Abbott voluntarily recalled selected Similac, Alimentum and EleCare powdered formulas. The plant shutdown contributed to a severe United States infant-formula shortage and generated congressional, legal and regulatory scrutiny.

  4. 2022

    Infant-formula supply shortage and government scrutiny

    Because Abbott was one of the largest United States infant-formula suppliers, the Sturgis recall and production suspension had effects beyond the recalled products. The episode intensified scrutiny of industry concentration, WIC supply arrangements, production resilience, regulatory oversight and the company's crisis communications.

  5. 2022

    Abbott recalls certain ready-to-feed formula products over bottle-cap sealing defect

    Recall announced

    Abbott announced a recall of some ready-to-feed liquid formula products for infants and children, including Similac and Pedialyte Electrolyte Solution. Abbott said caps on a small percentage of bottles in the recalled lots may not have sealed completely, which could result in spoilage and gastrointestinal symptoms if consumed.

    Company response

    • Remediation — Abbott

      We internally identified the issue, are addressing it, and will work with our customers to minimize inconvenience and get them the products they need

    Source excerpt

    • Abbott Laboratories announced on Friday the recall of some ready-to-feed baby formula liquid products for infants and children, including the brands Similac and Pedialyte Electrolyte Solution, due to bottle deficiency, according to their website.
    • These products are being recalled because a small percentage of bottles (less than 1%) in the recalled lots have bottle caps that may not have sealed completely, which could result in spoilage,
    • The recall was prompted by concerns over spoilage as a result of bottle caps not being sealed completely.
  6. 2022

    Shoppers Drug Mart recalls certain Abbott infant formula products

    Recall announced

    Shoppers Drug Mart locations recalled certain Abbott brand powdered infant formula products due to potential Cronobacter sakazakii and Salmonella contamination.

    Source excerpt

    • Shoppers Drug Mart locations is recalling certain baby formulas as they could have been contaminated with salmonella.
    • The recall for certain Abbott brand powdered infant formula products was made June 19 due to potential Cronobacter sakazakii and Salmonella contamination, according to the Canadian Food Inspection Agency.
    • The warning says Shoppers Drug Mart is recalling certain Abbott-brand powdered infant formula products from the marketplace due to possible Cronobacter sakazakii and salmonella contamination.
  7. 2022

    Abbott apologizes for US baby formula shortage

    Company response

    Abbott CEO Robert Ford apologized to US families affected by the baby formula shortage. The article says Abbott's voluntary recall had exacerbated the shortage.

    Company response

    • Apology — Abbott

      The head of baby formula manufacturer Abbott apologised Saturday to US families affected by the shortage of the essential supply.
    • Refund or compensation — Abbott

      He said Abbott will set up a US$5 million fund for the families of children who were hospitalised after consuming the recalled formula.
    • Remediation — Abbott

      Ford also said the manufacturer was taking “serious steps” to alleviate the shortage, such as converting production lines for adult goods at its factory in Columbus, Ohio to “prioritise” making formula.

    Source excerpt

    • The CEO of Abbott, the company whose voluntary recall of several widely sold baby formula brands helped trigger a nationwide formula shortage, has apologized for the crisis, as the first overseas shipment of formula approved by President Biden arrived in the U.S. Sunday.
    • Abbott will establish a $5 million fund to help those families with medical and living expenses until the supply crisis is relieved, Ford announced.
    • "We're sorry to every family we've let down since our voluntary recall exacerbated our nation's baby formula shortage," wrote CEO Robert Ford in an op-ed published Saturday in the Washington Post.
  8. 2022

    Government report describes possible Abbott formula contamination

    Hazard disclosure

    A news report citing a latest government document said investigators found that infant formula made at Abbott's Michigan facility may have been contaminated months before the recall. The article also reports that investigators said contaminants, including Cronobacter, could potentially have been transferred to formula; it does not establish that the potentially affected batch was distributed.

    Company response

    • Apology — Abbott

      We deeply regret the concern and inconvenience this situation will cause parents, caregivers and health care professionals.

    Source excerpt

    • 据媒体报道,一份最新政府文件显示,联邦调查人员发现雅培实验室工厂生产的婴儿配方奶粉有可能在召回前几个月就已经受到污染
    • 报告称,有记录显示,雅培在一批成品配方中检测到克罗诺杆菌,这些配方可能是由一名工人在没有更换手套的情况下接触了受污染的表面,所幸的是,那批货没有分发出去。
    • Abbott, one of the country's largest infant formula makers, said it is recalling all potentially affected products manufactured at the Sturgis, Michigan facility.
  9. 2022

    Abbott recalls six lots of Similac Alimentum in Vietnam

    Recall announced

    Abbott Laboratories GmbH’s Hanoi representative office announced a voluntary recall in Vietnam of six lots of Similac Alimentum Eye-Q powdered infant formula because they potentially contained two kinds of dangerous bacteria. The article reports that 7,050 cartons had entered the market and that the importer notified customers about the recall.

    Company response

    • Recall — Abbott

      The representative office of Abbott Laboratories GmbH in Hanoi has announced a voluntary recall of six lots of Similac Alimentum Eye-Q products in Vietnam as they potentially contain two kinds of dangerous bacteria, Vietnam’s food safety authorities have reported.

    Source excerpt

    • The representative office of Abbott Laboratories GmbH in Hanoi has announced a voluntary recall of six lots of Similac Alimentum Eye-Q products in Vietnam as they potentially contain two kinds of dangerous bacteria, Vietnam’s food safety authorities have reported.
    • A total of 11,320 cartons of Similac Alimentum Eye-Q, with six 400-gram cans per carton, has been imported into Vietnam by Ho Chi Minh City-based 3A Nutrition (Vietnam) Company Limited.
    • The importer has sent a notice to its customers about the recall of this infant formula item in Vietnam.
  10. 2022

    Abbott recalls three infant formula products

    Recall announced

    Abbott recalled three infant formula products after Cronobacter sakazakii was found in a non-product-contact area of a Michigan factory; the source says the products could pose a health risk to infants aged 0–6 months and that the investigation was ongoing.

    Company response

    • Investigation — Abbott

      但没有证据显示存在沙门氏菌,目前调查仍在进行中
    • Recall — Abbott

      当地时间2月17日,雅培全球官网发布主动召回信息

    Source excerpt

    • 但没有证据显示存在沙门氏菌,目前调查仍在进行中。
    • 此次召回的奶粉,在工厂的非产品接触区域发现了阪崎肠杆菌,对0至6月龄婴儿可能存在健康风险。
    • 近日,雅培全球官网主动召回3款婴儿配方奶粉。
  11. 2022

    Vietnam orders recall of certain Abbott formula products

    Recall announced

    Vietnam's Food Safety Authority issued a recall of certain potentially contaminated food products sold by Abbott after reports of contamination incidents in the U.S. The agency contacted importers and asked them to recall the products.

    Company response

    • Recall — Abbott

      In a Feb. 17 press release on Abbott's website, the firm has issued a recall for certain powder formulas including Similac, Alimentum and Elecare manufactured at a plant in Sturgis, Michigan.

    Source excerpt

    • some children were infected with the Cronobacter sakazakii or Salmonella newport bacteria after consuming formula food products produced at a factory by Abbott Nutrition in the U.S.
    • The Vietnam Food Safety Authority has issued a recall of certain potentially contaminated food products sold by U.S. multinational Abbott after four contamination incidents in the U.S.
    • The Vietnamese agency has contacted the companies that imported the products and asked that they are recalled.
  12. 2021

    Abbott's Shanghai entity fined over advertising violations

    Fine or penalty

    The Shanghai Municipal Administration for Market Regulation fined Abbott Trading (Shanghai) Co., Ltd. RMB 848,000 and ordered it to stop publishing advertisements for medical services, medicines and medical devices that violated regulations.

    Source excerpt

    • 近日,因违规发布医疗、药品、医疗器械广告,雅培贸易(上海)有限公司(以下简称“雅培”)被上海市市场监督管理局处以罚款84.8万元,并责令停止发布。